More on KKR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $95.59 |
|
|||
| Open | $93.06 | ||||
| 52 Wk High | $17.84 | ||||
| 52 Wk Low | $10.89 | ||||
| Day High | $93.06 | ||||
| Day Low | $89.11 | ||||
| P/E | 39.71 | ||||
| EPS | $2.30 | ||||
| Volume | 9,264,652 | ||||
- Form 4 KKR & Co. Inc. For: Mar 04 Filed by: BARAKETT TIMOTHY R
- BlackRock marks $25 million private loan as worthless after three months - Bloomberg
- Form 4 KKR & Co. Inc. For: Feb 27 Filed by: BAE JOSEPH Y
- Form 4 KKR & Co. Inc. For: Mar 02 Filed by: Dillon Mary N
- Form 4 KKR & Co. Inc. For: Feb 27 Filed by: NUTTALL SCOTT C
- Blackstone sinks after $1.7 bln net outflows from flagship private credit fund
- Esperion to acquire Corstasis for $75 million plus milestones
- Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
- KKR (KKR) PT Lowered to $127 at Barclays
- Form DEFA14A KKR & Co. Inc.
Entities mentioned with KKR
- Hedge Funds | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Morgan Stanley | View Related Stories »
- Dividend | View Related Stories »
- Goldman Sachs | View Related Stories »
- ARK | View Related Stories »
- Show More...
